GCIG
VCYT icon

Grand Central Investment Group’s Veracyte VCYT Stock Holding History

Grand Central Investment Group’s Portfolio VCYT Stock Details VCYT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-18,858
Closed -$1.01M – 39
2021
Q1 		$1.01M Sell
18,858
-234
-1% -$13.5K 0.99% 23
2020
Q4 		$934K Buy
+19,092
New +$885K 0.84% 25

Other funds holding VCYT

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Grand Central Investment Group's VCYT Position: Q2 2021 in Review

Grand Central Investment Group sold out of Veracyte (VCYT) in Q2 2021, closing a stake of 18,858 shares — an estimated $1.01M sold.

Grand Central Investment Group first reported a position in VCYT in Q4 2020 and held it in 2 quarters. The position peaked at $1.01M in Q1 2021. 214 funds tracked by Wall St. Rank hold VCYT as of Q2 2021.

  • Grand Central Investment Group reported no remaining Veracyte position as of Q2 2021 after selling out during the quarter.
  • Grand Central Investment Group sold 18,858 Veracyte shares in Q2 2021, an estimated $1.01M.
  • Grand Central Investment Group first reported a position in Veracyte in Q4 2020 and held it in 2 quarters.
  • Grand Central Investment Group's Veracyte position peaked at $1.01M in Q1 2021.
  • 214 funds tracked by Wall St. Rank held Veracyte as of Q2 2021.

Based on Grand Central Investment Group's 13F filing for Q2 2021, filed 9 Aug 2021.